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The CD16+ subset of monocytes is dramatically expanded in peripheral blood during progression to AIDS, but its contribution to HIV
pathogenesis is unknown. Here, we demonstrate that CD16+ but not CD16 monocytes promote high levels of HIV replication upon
differentiation into macrophages and interaction with T cells. Conjugates formed between CD16+ monocyte-derived macrophages and T cells are
major sites of viral replication. Furthermore, similar monocyte–T cell conjugates detected in peripheral blood of HIV-infected patients harbor HIV
DNA. Thus, expansion of CD16+ monocytes during HIV infection and their subsequent recruitment into tissues such as lymph nodes, brain, and
intestine may contribute to HIV dissemination and establishment of productive infection in T cells.
D 2005 Elsevier Inc. All rights reserved.Keywords: HIV; CD16+ monocytes; T cells; ConjugatesIntroduction
Peripheral blood monocytes consist of subsets with
distinct phenotypic and functional characteristics. The ex-
pression of CD16 (FcgRIII) identifies a subset of monocytes
(Mo) (Grage-Griebenow et al., 2001; Ziegler-Heitbrock,
1996) that is dramatically expanded in peripheral blood of
human immunodeficiency virus type 1 (HIV)-infected indi-
viduals (Thieblemont et al., 1995), particularly during
progression to AIDS (Pulliam et al., 1997). CD16+ Mo
produce high levels of pro-inflammatory cytokines and share
phenotypic and functional characteristics with macrophages
(MA) and dendritic cells (DC) (Grage-Griebenow et al.,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.10.027
Abbreviations: DC-SIGN, DC-specific intercellular adhesion molecule-
grabbing integrin; Mo, monocytes; MA, macrophages; Mo/MA, monocyte-
derived macrophages; HIV, human immunodeficiency virus; GFP, green
fluorescence protein; VSVG, vesicular stomatitis virus glycoprotein; RT,
reverse transcriptase.
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Ziegler-Heitbrock, 1996). Mo-derived MA are an important
cellular target for HIV replication, whereas DC capture HIV
and promote trans-infection of T cells (Stevenson, 2003).
HIV replication is restricted in Mo, with productive infection
requiring differentiation into MA (Crowe et al., 2003; Triques
and Stevenson, 2004). In HIV-infected patients, circulating
Mo are a minor viral reservoir compared to CD4+ T cells
(Crowe et al., 2003). However, Mo bind HIV and support
viral entry (Triques and Stevenson, 2004) and therefore have
the potential to contribute to HIV dissemination upon
recruitment into peripheral tissues (Crowe et al., 2003).
Because CD16+ Mo are at an advanced stage of Mo
differentiation, it has been proposed that this Mo subset
may be a preferential target for HIV infection (Crowe et al.,
2003). However, the contribution of the CD16+ Mo subset to
HIV pathogenesis is unknown. Here, we investigated the
ability of CD16+ and CD16 Mo subsets to replicate HIV
and promote productive infection upon differentiation and
interaction with T cells.6) 267 – 276
www.e
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HIV-pulsed CD16+ monocytes promote productive infection
upon co-culture with activated T cells
CD16+ and CD16 Mo subsets were isolated from PBMC
of healthy uninfected individuals (Fig. 1A), exposed to
replication competent CCR5 (R5) YU2 or CXCR4-using
(X4) NDK HIV, cultured for 3 days, and then co-cultured withFig. 1. HIV-pulsed CD16+ monocytes promote HIV replication upon co-culture with
analyzed by FACS for CD14 and CD16 expression and (B) the purity of the CD4+ T
representative of experiments performed with cells from 20 different donors. CD1
cultured in the presence or absence of PHA-activated autologous T cells (TPHA). (C)
10 post-infection. (D–E) Supernatants were tested for RT activity. Results are repre
panel), 6 (E, left panel), and 1 (E, right panel) different donors (mean T SD of dupPHA-stimulated autologous CD4+ T cells (TPHA) (Fig. 1B).
Both Mo subsets acquired an MA-like morphology by day 10
post-infection (Fig. 1C) and exhibited similar cell viability
when co-cultured with TPHA for up to 24 days (data not
shown). Levels of HIV replication were variable between
different donors, consistent with previous studies (Eisert et al.,
2001). In Mo-derived MA cultured alone, HIV replication
varied from undetectable to low but significant, with no
significant differences between the Mo subsets (Figs. 1D–E).activated T cells. (A) Freshly isolated CD16+ and CD16 monocytes (Mo) were
cell fraction was determined after staining with CD3 and CD4 Abs. Results are
6+ and CD16 Mo were pulsed with HIV YU2 or NDK for 3 days and then
Shown are phase contrast pictures of Mo-derived macrophages (Mo/MA) at day
sentative of experiments performed with cells from 3 (D, left panel), 4 (D, right
licate wells) (*P < 0.05, Student’s t test, CD16+ vs. CD16 Mo:TPHA).
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genous IL-2 was added (data not shown). When HIV-pulsed
Mo were co-cultured with TPHA, HIV replication increased
dramatically in the absence of exogenous IL-2 (Figs. 1D–E).
Co-culture of HIV-pulsed Mo with unactivated T cells resulted
in low levels of HIV replication that were close to the limit of
detection (data not shown). Levels of reverse transcriptase (RT)
activity were significantly higher in CD16+ compared to
CD16 Mo:TPHA co-cultures in all donors tested (Figs. 1D–
E). The pattern of YU2 replication in Mo:TPHA co-cultures
distinguished 2 groups of donors. In the first group (n = 3/7),
YU2 replicated to high levels in CD16+ Mo:TPHA co-cultures,
but not in CD16 Mo:TPHA co-cultures or Mo/MA subsets
cultured alone (Fig. 1D, left). In the second group (n = 4/7),
YU2 replication was detected in CD16 Mo:TPHA co-cultures,
but at lower levels compared to CD16+ Mo:TPHA co-cultures
(Fig. 1D, right). The pattern of NDK replication was more
consistent between donors. In the majority of donors (n = 6/7),
high levels of NDK replication were detected in CD16+ but not
CD16Mo:TPHA co-cultures or Mo/MA subsets cultured alone
(Fig. 1E). Thus, CD16+ Mo exhibit a superior capacity to
promote high levels of HIV replication upon differentiation
into MA and interaction with T cells.
CD16+ Mo/MU:T cell conjugates are major sites of HIV
replication
To identify cellular sites of productive HIV infection in Mo:T
co-cultures, CD16+ and CD16 Mo were pulsed with an R5
HIV expressing GFP, NL4.3-BaL-GFP. Staining for intracellu-
lar HIV-p24 and FACS analysis demonstrated that GFP and
HIV-p24 were co-expressed (data not shown), thus allowing
identification of HIV-infected cells as GFP+ cells. Cell clusters
consisting of Mo/MA in contact with T cells were frequent in
both CD16+ and CD16 Mo:T co-cultures. However, the
frequency of GFP+ cells and syncytia formation within clusters
was significantly higher in CD16+ Mo:T co-cultures (Fig. 2A).
Staining with CD3 and CD33 Abs distinguished three
subpopulations of cells: T cells (CD33CD3+), Mo/MA
(CD33+CD3), and conjugates formed between Mo/MA and
T cells (CD33+CD3+) (Fig. 2B). At the peak of HIV replication,
T cell counts and the frequency of conjugates were similar in
CD16+ and CD16 Mo:T co-cultures (Figs. 2C–D). However,
the frequency of GFP+ cells and RT levels were significantly
higher in CD16+ compared CD16 Mo:T co-cultures (Figs.
2E–G). The GFP+ cell fraction in CD16+ Mo:T co-cultures
consisted of similar numbers of T cells, Mo/MA, and Mo/MA:T
conjugates, but the highest frequency of GFP+ cells was in
CD16+ Mo/MA:T conjugates (Figs. 2E–F). Thus, both T cells
and Mo/MA were productively infected with HIV, but
conjugates formed between HIV-pulsed CD16+ Mo/MA and
T cells were predominant sites of viral replication.
The capacity of CD16+ Mo to support high levels of HIV
infection upon differentiation and co-culture with T cells raised
the question of whether HIV replication was detectable in
CD16+ Mo prior to co-culture with T cells. To investigate this
question, CD16+ Mo were pulsed with NL4.3-BaL-GFP for 3days and then co-cultured with TPHA in the presence or absence
of the RT inhibitor AZT. Treatment with AZT dramatically
suppressed the detection of GFP-expressing CD16+ Mo/MA
and RT levels in CD16+ Mo:T co-cultures to levels that were
comparable to or only slightly above background (Figs. 2F–
G). Thus, detectable levels of viral replication in CD16+ Mo/
MA did not occur by day 3 post-infection, and no further
cycles of HIV replication took place in Mo/MA or T cells after
AZT treatment. We also compared the susceptibility of Mo
subsets to HIV replication before and after differentiation into
MA. Freshly isolated Mo, or Mo differentiated into MA by
culturing with M-CSF, were exposed to pseudotyped VSVG-
HIV-GFP. Infection by VSVG-HIV-GFP was restricted in both
Mo subsets prior to differentiation (Fig. 2H, top). Following
differentiation into MA, both subsets became highly permis-
sive (Fig. 2H, bottom). Thus, higher levels of HIV replication
in CD16+ Mo:T co-cultures were not explained by preferential
susceptibility of CD16+ Mo/MA to productive HIV infection
prior to co-culture with activated T cells.
HIV binding via CD4 is required for productive infection in
CD16+ Mo:T co-cultures
The preceding results raised the possibility that CD16+ Mo
may bind and/or internalize HIV more efficiently compared to
CD16 Mo. To investigate this possibility, freshly isolated
CD16+ and CD16 Mo were analyzed for expression of the
HIV attachment molecule DC-SIGN (Geijtenbeek et al., 2000)
and HIV receptor CD4 and co-receptors CCR5 and CXCR4
(Eisert et al., 2001). Both Mo subsets lacked expression of DC-
SIGN and expressed similar high levels of CD4, whereas
expression of CCR5 and CXCR4 was slightly higher and lower,
respectively, on CD16+ compared to CD16 Mo (Fig. 3A). We
then investigated the ability of Mo subsets to bind HIV by
measuring levels of cell-associated HIV-p24 after exposure to
HIV YU2 at 4 or 37 -C. Surprisingly, CD16+ Mo bound HIV
less efficiently than CD16 Mo (Fig. 3B). To determine
whether virus attached to Mo at 37 -C remained on the cell
surface or was internalized, cell surface-bound HIV was
removed by treatment with pronase. Pronase treatment reduced
HIV-p24 levels associated with both Mo subsets by approxi-
mately 50% (Fig. 3C), indicative of HIV internalization. Pre-
incubation with a neutralizing CD4 Ab (10 Ag/ml) or the C-type
lectin receptor (CLR) ligand mannan (5 mg/ml) (Turville et al.,
2001) had only minor inhibitory effects on HIV binding and
internalization (Fig. 3C and data not shown). In control
experiments, the same concentration of mannan significantly
decreased HIV binding to DC-SIGN-expressing Mo/MA
(prepared by co-culturing Mo with T cells, which induces
DC-SIGN expression) by 50% (data not shown), indicating that
mannan was functioning properly under these assay conditions.
Incubation with CD4 Ab before exposing Mo to HIV
dramatically reduced viral replication in CD16+ Mo:TPHA co-
cultures (Fig. 3D). Thus, CD16+ and CD16 Mo can bind and
internalize HIV in a CD4- and CLR-independent manner, but
virus entry mediated by a CD4-dependent pathway is required
for productive infection in Mo:T cell co-cultures.
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The results obtained in vitro (Fig. 2B) prompted us to
investigate whether CD16+ Mo form conjugates with T cells in
vivo. Double staining with CD14 and CD3 Abs identified
conjugates formed between Mo and T cells in peripheral bloodFig. 2. CD16+ Mo/MA:T cell conjugates are major sites of HIV replication. CD16
cultured with TPHA in the presence or absence of AZT. (A) Shown are fluorescen
harvested at day 14 post-infection were double stained with CD33 and CD3 Abs and
cells (CD33CD3+), Mo/MA (CD33+CD3), and Mo/MA:T conjugates (CD33+CD3
by FACS using fluorescent beads (mean T SEM, n = 4). (E) Cell subsets, gated ba
forward scatter (FSC, size) characteristics. (F) The number and the percentage o
determined by FACS and (G) RT activity was quantified in the supernatants (mean T
subsets were incubated with VSVG-HIV-GFP at day 0 or after 5 days of culture in the
2 days later. Results are representative of experiments performed with cells from 2of AIDS patients (Fig. 4A). The frequency of conjugates was
0.4–5.4% in HIV-infected patients receiving HAART (median
plasma viral load 400; range 75–1,000,000 HIV RNA copies/
ml and median CD4 counts 37; range 11–409 cells/Al, n = 11
of whom 10 were intravenous drug users) compared to <0.1%
in uninfected individuals (n = 20) (Figs. 4A–B and data not+ and CD16 Mo were pulsed with NL4.3-BaL-GFP for 3 days and then co-
t and phase contrast pictures at day 14 post-co-culture. (B) Mo:T co-cultures
analyzed by FACS. CD33 and CD3 expression distinguish three populations: T
+). (C–D) Numbers of T cells and conjugates in Mo:T co-cultures were counted
sed on the CD33 and CD3 expression, were analyzed for GFP expression and
f GFP+ cells in cell subsets from CD16+ and CD16 Mo:T co-cultures was
SEM, n = 4). (*P < 0.05, Student’s t test, CD16+ vs. CD16Mo:TPHA) (H) Mo
presence of M-CSF. GFP expression was analyzed by fluorescence microscopy
different donors.
Fig. 2 (continued).
Rapid Communication 271shown). The frequency of conjugates did not correlate with
plasma viral loads (Spearman correlation 0.506; P = 0.116) or
CD4 counts (Spearman correlation 0.109; P = 0.749). Triple
staining with CD14, CD3, and CD16 Abs indicated that both
CD16+ and CD16Mo subsets formed conjugates with T cells.
The frequency of CD16+ Mo was slightly higher within
conjugates compared to that in the total Mo (tMo) fraction
(Fig. 4C), indicating a slightly greater or at least equal capacity
of CD16+ compared to CD16 Mo to form conjugates with T
cells. Triple staining with CD14, CD3, and CD4 or CD8 Abs
demonstrated that a small fraction of CD14+CD3+ conjugates
expressed high levels of CD4 (median 6; range 3.6–11.3%, n =
7), whereas the majority of T cells conjugated with Mo
expressed CD8 (data not shown). Conjugates typically
consisted of one or two CD3+ T cells bound to one CD14+
Mo (Fig. 4D). The phenotype of Mo:T conjugates was
intermediate between that of tMo and T cells. Conjugates
expressed the Mo markers CD14 and CD33, T cell markers
CD2 and CD3, HIV co-receptors CCR5 and CXCR4,
activation markers CXCR3, HLA-DR, CD25, and CD69, and
adhesion molecules CD62L, CX3CR1, PSGL-1, VLA4, and
VCAM-1, and lacked expression of the DC markers CD83 and
DC-SIGN (Fig. 4E and data not shown). HIV DNA was
quantified in CD14+CD3+ conjugates and CD4+ T cells
isolated from AIDS patients receiving HAART (plasma viralload and CD4 count range 5950–17,200 HIV RNA copies/ml
and 15–102 cells/Al, respectively; n = 3 of whom 2 were
intravenous drug users) by nested real time PCR. Higher viral
DNA copy numbers were detected in T cells compared to Mo:T
conjugates. However, when HIV DNA copy number was
normalized to the frequency of CD4high conjugates within each
patient, viral loads in Mo:T conjugates were similar to those in
T cells (Fig. 4F). Thus, Mo:T cell conjugates that harbor HIV
DNA are present in the peripheral blood of HIV-infected
individuals.
Discussion
In this study, we demonstrate that CD16+monocytes
exposed to HIV promote highly efficient viral replication upon
differentiation into macrophages and interaction with CD4+ T
cells. We also show that conjugates formed between CD16+
Mo-derived MA and T cells are major sites for productive HIV
infection in vitro. Furthermore, similar conjugates formed
between CD16+ Mo and CD4+ T cells are present in peripheral
blood of HIV-infected patients. These conjugates harbor HIV
DNA and may therefore represent sites for initiation of HIV
replication. Thus, expansion of CD16+ Mo in peripheral blood
of HIV-infected patients (Pulliam et al., 1997; Thieblemont et
al., 1995) and their subsequent recruitment into tissues (Ancuta
Fig. 3. HIV binding and internalization by CD16+ and CD16Mo. (A) Expression of DC-SIGN, CD4, CCR5, and CXCR4 on CD16+ and CD16Mo was analyzed
by FACS. Results are representative of experiments performed with cells from 3 different donors. (B) Mo subsets were incubated in the presence or absence of R5
HIV YU2 at 37 or 4 -C. (C) Mo were pre-incubated in the presence or absence of CD4 Ab and then pulsed with HIV at 37 -C. HIV-pulsed Mo were treated or not
with pronase. HIV p24 levels in cell lysates were quantified by ELISA. Results are representative of experiments performed with cells from 3 different donors. (D)
CD16+ Mo were incubated in the presence or absence of CD4 Ab before exposure to HIV YU2 and, at day 3 post-infection, co-cultured with TPHA. Supernatants
were tested for RT activity. Results are representative of experiments performed with cells from 2 different donors.
Rapid Communication272et al., 2003) may contribute to HIV dissemination and
productive infection in T cells in vivo.
When CD16+ and CD16Mowere exposed to R5 or X4HIV
and then co-cultured with activated T cells, high levels of
productive infection occurred only in CD16+ Mo/MA:T co-
cultures. Cells replicating HIV consisted of Tcells, Mo/MA, and
conjugates formed between Mo/MA and T cells. HIV-pulsed
CD16+ and CD16Mo/MA formed conjugates with T cells at a
similar frequency. However, only CD16+ Mo/MA:T conjugates
were major sites for productive HIV infection. Conjugate
formation between T cells and CD16+ versus CD16 Mo
subsets may involve distinct molecular mechanisms with
different consequences for HIV replication. HIV-pulsed DC
form a stable adhesive junction with Tcells, termed an infectioussynapse, which facilitates HIV transmission from DC to T cells
(McDonald et al., 2003). Conjugates formed by DC or MAwith
T cells support productive HIV infection (Hladik et al., 1999;
Pope et al., 1994). By analogy, HIV-pulsed CD16+Mo/MAmay
form an infectious synapse upon conjugation with Tcells, which
may facilitate efficient cell-to-cell transmission of HIV. Cell-to-
cell contact within conjugates may also lead to CD16+ Mo/MA-
triggered T cell activation for susceptibility to HIV replication
via membrane-bound molecules and/or production of soluble
factors (Thieblemont et al., 1995). Conjugation between HIV-
pulsed CD16+ Mo/MA and T cells leads to cytopathic effects
including syncytia formation and cell loss, as previously
demonstrated for DC–T conjugates (Pope et al., 1994) and
suggested by the appearance of syncytia within Mo/MA:T cell
Fig. 4. CD16+ Mo form conjugates with T cells in vivo. (A) Mo:T cell conjugates were identified in PBMC of HIV-infected donors as CD3+CD14+ events, and (B)
the frequency of conjugates was determined by FACS in 11 different donors. (C) Total Mo (tMo) and Mo:T cell conjugates were analyzed by FACS for CD14 and
CD16 expression. (D) CD3+ fraction was isolated from PBMC using CD3 beads. Conjugates were further isolated by adherence to plastic, stained with CD3 Ab, and
analyzed by confocal microscopy. (E) Mo:T conjugates, tMo, and CD4+ T cells were analyzed by FACS for the expression of HIV co-receptors, activation markers,
and adhesion molecules. Results are representative of experiments performed with 3–16 donors. (F) CD14+CD3+ Mo:T conjugates and CD4+ T cells were isolated
by FACS and HIV DNA copy numbers were quantified in cell lysates by nested real time PCR using primers specific for HIV gag. HIV DNA content was further
normalized per number of CD4high conjugates within each patient.
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Rapid Communication274clusters at the peak of HIV replication (Fig. 2A). Further studies
are required to elucidate mechanisms involved in conjugate
formation between CD16+ Mo and T cells and the role of such
conjugates in HIV pathogenicity in vivo.
The superior capacity of CD16+ Mo/MA:T co-cultures to
support productive HIV infection was not explained by a
greater susceptibility of CD16+ Mo/MA to HIV replication
prior to co-culture with activated T cells. Furthermore, AZT
inhibition studies indicated that HIV replication was not
detectable in CD16+ Mo/MA up to day 3 post-infection. Our
findings also demonstrated that differences in the efficiency of
HIV replication in CD16+ and CD16Mo:T co-cultures are not
explained by a differential capacity of these Mo subsets to bind
and/or internalize HIV. In fact, HIV bound less efficiently to
CD16+ than to CD16 Mo and both Mo subsets internalized
HIV with similar efficiency. Blocking experiments indicated
that HIV binding and internalization in both Mo subsets can
occur independently of CD4, DC-SIGN, and other mannose
binding C-type lectin receptors (CLR) (Turville et al., 2001).
However, a CD4-dependent pathway was required for CD16+
Mo to promote efficient viral replication upon cell-to-cell
contact with T cells. Together, these findings suggest that
productive infection is initiated in CD16+ Mo/MA at low
levels, with progeny virions transferred from Mo/MA to T cells
within conjugates and subsequent cycles of viral replication
stimulated by CD16+ Mo/MA–T cell interactions.
The biological relevance of our results is supported by the
finding that CD16+ and CD16Mo form conjugates with CD4+
T cells in peripheral blood of HIV-infected patients with AIDS,
but not in uninfected individuals. Consistent with this finding,
previous studies identified conjugates formed between DC and
T cells in peripheral blood, and in skin and cervical tissue
explants, and demonstrated that DC–T cell conjugates become
rapidly and productively infected with HIV in vitro (Pope et al.,
1994; Weissman et al., 1995). We found that the frequency of
Mo–T conjugates in HIV-infected individuals did not correlate
significantly with CD4 counts or plasma viral loads in a small
sample size (n = 11 subjects). However, the P value was
possibly marginally significant (P = 0.116) for correlation with
viral load, so analysis of a larger cohort is needed to address this
question more definitively. Mo–T conjugates in HIV-infected
subjects exhibited an activated phenotype and expressed
adhesion molecules and chemokine receptors (Ancuta et al.,
2003), raising the possibility that cells within these conjugates
may attach onto activated endothelial cells and, possibly,
undergo transendothelial migration in vivo. Both CD16+ and
CD16Mo formed conjugates with T cells, but the frequency of
CD4+ T cells forming conjugates with Mo was significantly
lower compared to CD8+ T cells. Importantly, HIV DNA was
detected in Mo:T conjugates isolated from AIDS patients
receiving HAART. Furthermore, the HIV DNA copy number
normalized for the frequency of CD4high conjugates within a
given patient was similar to that in CD4+ T cells. Considering
the superior capacity of CD16+ Mo to promote HIV replication
in T cells in vitro (Figs. 1, 2), conjugates formed between
CD16+ Mo and CD4+ T cells in peripheral blood or other tissues
may represent sites for initiation of productive infection in vivo.In summary, these results suggest a model in which a low
level of HIV infection is initiated in CD16+ Mo exposed to HIV
upon their differentiation into MA, with progeny virions
transferred from Mo/MA to T cells within Mo/MA:T cell
conjugates. Subsequently, high levels of HIV replication occur
in T cells within these conjugates, with CD16+ Mo/MA–T cell
interactions creating a favorable environment for virus replica-
tion. The superior capacity of CD16+ Mo/MA to promote
productive infectionwithinMo/MA:Tcell conjugates may result
from a greater ability to deliver activator signals to Tcells and/or
to mediate cell-to-cell transmission of virions within an
infectious synapse. Given the potential of CD16+ Mo to migrate
preferentially in response to FKN (Ancuta et al., 2003), CD16+
Mo exposed to HIV in peripheral blood may be recruited into
tissues expressing FKN, such as lymph nodes (Foussat et al.,
2001), brain (Pereira et al., 2001), and intestine (Muehlhoefer et
al., 2000), and then subsequently promote HIV replication in T
cells. Thus, new therapies aimed at decreasing the frequency of
CD16+ Mo in peripheral blood may be beneficial for HIV-
infected patients.
Materials and methods
Reagents and antibodies
The following mAbs were used for FACS analysis: FITC
anti-CD14 and -CD16b, PE anti-CD33, -CD19, and -CD56,
PC5 anti-CD16 and -CD3 (Beckman Coulter), PE anti-HLA-
DR, -CD25, -CD69, CD4, -CCR4, -CCR5, -CXCR3, -CXCR4,
-DC-SIGN, -CD1a, and -DC-SIGN (BD Pharmingen), -CD1c
(Miltenyi), and CX3CR1 (MBL International).
Cell separation
PBMC were isolated from human peripheral blood. The
study protocol and informed consent forms were approved by
the Dana-Farber Cancer Institute IRB. Total monocytes (tMo)
were isolated from PBMC of healthy individuals by negative
selection (Miltenyi). The purity of the tMo fraction was >95%
with <2% T cell contamination, as assessed by triple staining
with CD14, CD16, and HLA-DR, CD3, CD19, CD56, CD16b,
or CD1c Abs and FACS analysis. CD16+ and CD16 Mo sub-
sets were isolated from tMo using CD16 immunobeads
(Miltenyi). Staining with CD14 and CD16 Abs showed >80%
CD16+Mo and >95% CD16Mo in the CD16+ and CD16Mo
fractions, respectively. CD4+ T cells were isolated from PBMC
by negative selection (Miltenyi). The purity of Tcells was >95%
as determined by staining with CD4 and CD3 mAbs and FACS
analysis.
HIV-1 binding and infection
HIV-1 stocks were prepared by transfection of 293 T cells
with the indicated plasmids using Fugene6 (Roche). Replica-
tion competent HIV viruses used were R5 YU2 and NL4.3-
BaL-GFP and X4 NDK. NL4.3-BaL-GFP is an NL4.3-based
provirus expressing the BaL envelope and gfp in place of nef. A
Rapid Communication 275replication-defective NL4.3 provirus pseudotyped with the
vesicular stomatitis virus glycoprotein (VSVG) and expressing
gfp in place of nef (VSVG-HIV-GFP) was used for single-cycle
infections. Mowere incubated in the presence or absence of anti-
CD4 Ab (Q4120, Calbiochem, 20 Ag/ml) or mannan (SIGMA, 5
mg/ml) for 30 min at 4 -C and then pulsed with HIV YU2
(20,000 3H cpm RT units) for 3 h at 37 or 4 -C. Unbound virus
was removed by extensive washing, and membrane-bound
virions were removed by treatment with pronase (7 mg/ml,
Roche) for 10 min at 4 -C. Cells were lysed, and HIV-p24 levels
were quantitated by ELISA (Perkin Elmer). Mo were incubated
with HIV YU2, NDK, or NL4.3-BaL-GFP (20–40,000 3H cpm
RTunits) for 3 h in 0.3 ml and then overnight in 1ml RPMI, 10%
FBS, 10 ng/ml M-CSF (R&D Systems). Unbound virus was
removed by extensive washing, and cells were cultured for 2
additional days. In parallel, autologous CD4+ T cells were
stimulated with PHA (1 Ag/ml) and IL-2 (5 ng/ml) (TPHA) for 3
days. At day 3 post-infection, HIV-pulsed Mo/MA were co-
cultured in the presence or absence of TPHA (Mo:T ratio 1:2) in
the presence or absence of AZT (SIGMA, 10 AM). Supernatants
were assessed for RT activity or HIV-p24 levels by ELISA.
Mo:Tco-cultures infected with NL4.3-BaL-GFP were harvested
at the peak of HIVreplication (day 14 post-infection) and stained
with CD33 and CD3 Abs. The percentage of GFP+ cells in T cell
(CD33CD3+), Mo/MA (CD33+CD3), and Mo/MA:T conju-
gate (CD33+CD3+) fractions was determined by FACS. Cells
were counted using Flow-Count fluorospheres (Beckman
Coulter).
Confocal microscopy visualization of Mo:T cell conjugates
The CD3+ cell fraction was isolated from PBMC of HIV-
infected individuals using CD3 magnetic beads (Miltenyi).
Mo:T cell conjugates were isolated from the CD3+ fraction by
adherence to collagen-coated multi-chamber slides. Conjugates
were stained with CD3 mAb and fixed using Cytofix/Cytoperm
(BD Pharmingen) and visualized by confocal microscopy.
Nested real time PCR quantification of HIV DNA
CD4+ T cells and CD14+CD3+ Mo:T cell conjugates were
isolated from PBMC of HIV-infected individuals by FACS
sorting after staining with CD14, CD4, and CD3 mAbs. Cell
pellets were lysed (2  106 cells/ml) using the PicoPure DNA
extraction kit (Arcturus). First, 12 cycles of PCR amplification
were carried out on 5 Al cell lysate by using PCR master mix
(Applied Biosystems) and the following primers: 767-LTR-F 5V
TAGCGGAGGCTAGAAGGAGAGA3V and 938-GAG-R
5VTTCGCAGTTAATCCTGGC3V. Then, 2 Al of the PCR
reaction was used for HIV-gag taqman quantitation using a
8E5 standard curve as described (Douek et al., 2002).
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